ASYMCHEM Sets 2026-2028 Dividend Framework, Commits to Minimum 10% Cash Payout Annually

Bulletin Express03-31

Asymchem Laboratories (Tianjin) Co., Ltd. (ASYMCHEM) has released a three-year Shareholder Dividend Return Plan covering 2026-2028, aimed at enhancing dividend transparency and ensuring sustainable returns.

Key elements of the plan are as follows:

1. Distribution Format • Dividends may be paid in cash, shares or a combination of both. • Cash dividends take priority whenever conditions permit.

2. Frequency • Subject to profit availability, at least one dividend distribution will be made each fiscal year, with the option for interim payouts.

3. Minimum Cash Dividend Ratio • Cash dividends will represent no less than 10% of the prior year’s distributable profit, provided normal operations and long-term development funding are secured. • When share dividends are proposed, the cash component will rise to a minimum of 80%, 40% or 20% depending on the company’s development stage and upcoming capital expenditure plans.

4. Conditions for Share Dividends • Share distributions may be considered when the company demonstrates rapid growth and the board deems the share price inconsistent with capital scale.

5. Governance and Oversight • Profit-distribution proposals require approval by more than half of all directors and a simple majority of shareholder votes at the general meeting. • Independent directors can propose alternative dividend plans and must issue opinions if they believe a proposal may harm minority shareholders. • The plan will be reviewed every three years and can be adjusted only through board and shareholder approval, particularly in response to major operational changes or new regulations.

6. Implementation Timeline • Once approved at the forthcoming general meeting, dividends are to be distributed within two months of the relevant resolution.

The board, chaired by Dr. Hao Hong, will circulate detailed documentation and convene a general meeting for shareholder approval. ASYMCHEM cautions investors that the plan’s adoption remains subject to shareholder endorsement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment